Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry

Total article views   HTML views PDF downloads Totals
4,516 Dovepress* 4,114+ 637 4,751
PubMed Central* 402 154 556
Totals 4,516 791 5,307
*Since 3 December 2020

View citations on PubMed Central and Google Scholar